{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T10:12:49Z","timestamp":1778753569818,"version":"3.51.4"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2019YFA0111000, 2022YFC2502700"],"award-info":[{"award-number":["2019YFA0111000, 2022YFC2502700"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82470166, 82200149, 82170158, 82100175, 82100170"],"award-info":[{"award-number":["82470166, 82200149, 82170158, 82100175, 82100170"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012246","name":"Priority Academic Program Development of Jiangsu Higher Education Institutions","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012246","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20231195, BK20210087"],"award-info":[{"award-number":["BK20231195, BK20210087"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018556","name":"Suzhou Science and Technology Program","doi-asserted-by":"crossref","award":["SYW2025092"],"award-info":[{"award-number":["SYW2025092"]}],"id":[{"id":"10.13039\/501100018556","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Open Project of Jiangsu Biobank of Clinical Resources","award":["SBK202003001, SBK202003003"],"award-info":[{"award-number":["SBK202003001, SBK202003003"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"DOI":"10.1007\/s00277-026-07030-z","type":"journal-article","created":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T03:49:51Z","timestamp":1777434591000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Combined blinatumomab and CD19 CAR T-cell therapy for newly diagnosed adult Ph\u207b BCP-ALL: A retrospective study"],"prefix":"10.1007","volume":"105","author":[{"given":"Boxuan","family":"Jiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiyan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yucheng","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiayi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yizi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suning","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,29]]},"reference":[{"issue":"6","key":"7030_CR1","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1200\/JCO.1994.12.6.1312","volume":"12","author":"A Preti","year":"1994","unstructured":"Preti A, Kantarjian HM (1994) Management of adult acute lymphocytic leukemia: present issues and key challenges. J Clin Oncol 12(6):1312\u20131322. https:\/\/doi.org\/10.1200\/JCO.1994.12.6.1312","journal-title":"J Clin Oncol"},{"issue":"3","key":"7030_CR2","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1200\/JCO.2000.18.3.547","volume":"18","author":"HM Kantarjian","year":"2000","unstructured":"Kantarjian HM, O\u2019Brien S, Smith TL et al (2000) Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia. J Clin Oncol 18(3):547\u2013561. https:\/\/doi.org\/10.1200\/JCO.2000.18.3.547","journal-title":"J Clin Oncol"},{"issue":"9","key":"7030_CR3","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1200\/JCO.2013.50.2708","volume":"32","author":"D Douer","year":"2014","unstructured":"Douer D, Aldoss I, Lunning MA et al (2014) Pharmacokinetics-based integration of multiple doses of intravenous pegaspargase in a pediatric regimen for adults with newly diagnosed acute lymphoblastic leukemia. J Clin Oncol 32(9):905\u2013911. https:\/\/doi.org\/10.1200\/JCO.2013.50.2708","journal-title":"J Clin Oncol"},{"issue":"4","key":"7030_CR4","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1182\/bloodadvances.2021005624","volume":"6","author":"AW Rijneveld","year":"2022","unstructured":"Rijneveld AW, van der Holt B, de Weerdt O et al (2022) Clofarabine added to intensive treatment in adult patients with newly diagnosed ALL: the HOVON-100 trial. Blood Adv 6(4):1115\u20131125. https:\/\/doi.org\/10.1182\/bloodadvances.2021005624","journal-title":"Blood Adv"},{"issue":"3","key":"7030_CR5","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1002\/ajh.27576","volume":"100","author":"H Kantarjian","year":"2025","unstructured":"Kantarjian H, Short NJ, Jain N et al (2025) Hyper-CVAD and Sequential Blinatumomab Without and With Inotuzumab in Young Adults With Newly Diagnosed Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic Leukemia. Am J Hematol 100(3):402\u2013407. https:\/\/doi.org\/10.1002\/ajh.27576","journal-title":"Am J Hematol"},{"issue":"1","key":"7030_CR6","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s13045-024-01597-8","volume":"17","author":"J Lu","year":"2024","unstructured":"Lu J, Qiu H, Wang Y et al (2024) Reduced-dose chemotherapy and blinatumomab as induction treatment for newly diagnosed Ph-negative B-cell precursor acute lymphoblastic leukemia: a phase 2 trial. J Hematol Oncol 17(1):79. https:\/\/doi.org\/10.1186\/s13045-024-01597-8","journal-title":"J Hematol Oncol"},{"issue":"4","key":"7030_CR7","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1056\/NEJMoa2312948","volume":"391","author":"MR Litzow","year":"2024","unstructured":"Litzow MR, Sun Z, Mattison RJ et al (2024) Blinatumomab for MRD-Negative Acute Lymphoblastic Leukemia in Adults. N Engl J Med 391(4):320\u2013333. https:\/\/doi.org\/10.1056\/NEJMoa2312948","journal-title":"N Engl J Med"},{"key":"7030_CR8","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s13045-025-01709-y","volume":"18","author":"NJ Short","year":"2025","unstructured":"Short NJ, Kantarjian H, Furudate K et al (2025) Molecular characterization and predictors of relapse in patients with Ph + ALL after frontline ponatinib and blinatumomab. J Hematol Oncol 18:55. https:\/\/doi.org\/10.1186\/s13045-025-01709-y","journal-title":"J Hematol Oncol"},{"issue":"5","key":"7030_CR9","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1200\/JCO.24.00321","volume":"43","author":"GW Roloff","year":"2025","unstructured":"Roloff GW, Aldoss I, Kopmar NE et al (2025) Outcomes After Brexucabtagene Autoleucel Administered as a Standard Therapy for Adults With Relapsed\/Refractory B-Cell ALL. J Clin Oncol 43(5):558\u2013566. https:\/\/doi.org\/10.1200\/JCO.24.00321","journal-title":"J Clin Oncol"},{"issue":"5","key":"7030_CR10","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1056\/NEJMoa1709866","volume":"378","author":"SL Maude","year":"2018","unstructured":"Maude SL, Laetsch TW, Buechner J et al (2018) Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia. N Engl J Med 378(5):439\u2013448. https:\/\/doi.org\/10.1056\/NEJMoa1709866","journal-title":"N Engl J Med"},{"issue":"6","key":"7030_CR11","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/s41571-019-0184-6","volume":"16","author":"NN Shah","year":"2019","unstructured":"Shah NN, Fry TJ (2019) Mechanisms of resistance to CAR T cell therapy. Nat Rev Clin Oncol 16(6):372\u2013385. https:\/\/doi.org\/10.1038\/s41571-019-0184-6","journal-title":"Nat Rev Clin Oncol"},{"key":"7030_CR12","unstructured":"National Comprehensive Cancer Network (NCCN).\u00a0NCCN Clinical Practice Guidelines in Oncology: Acute Lymphoblastic Leukemia. Version 3.2024. Published December 20, 2024. Accessed August 1, 2025. https:\/\/www.nccn.org\/guidelines\/guidelines-detail?category=1&id=149216.13."},{"issue":"16","key":"7030_CR13","doi-asserted-by":"publisher","first-page":"6529","DOI":"10.1200\/JCO.2025.43.16_suppl.6529","volume":"43","author":"H Zhou","year":"2025","unstructured":"Zhou H, Li Y, Wang J et al (2025) Real-world outcomes of inaticabtagene autoleucel in Chinese patients with B-ALL. J Clin Oncol. 43(16):6529\u20136529. https:\/\/doi.org\/10.1200\/JCO.2025.43.16_suppl.6529","journal-title":"J Clin Oncol."},{"issue":"10","key":"7030_CR14","first-page":"1346","volume":"90","author":"JM Ribera","year":"2005","unstructured":"Ribera JM, Oriol A, Bethencourt C, Parody R, Hern\u00e1ndez-Rivas JM, Moreno MJ, del Potro E, Torm M, Rivas C, Besalduch J, Sanz M\u00c1 (2005) Comparison of intensive chemotherapy, allogeneic or autologous stem cell transplantation as post-remission treatment for adult patients with high-risk acute lymphoblastic leukemia Results of the PETHEMA ALL-93 trial. Haematologica 90(10):1346\u201356","journal-title":"Haematologica"},{"issue":"4","key":"7030_CR15","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1182\/blood-2007-10-116582","volume":"111","author":"AH Goldstone","year":"2008","unstructured":"Goldstone AH, Richards SM, Lazarus HM, Tallman MS, Buck G, Fielding AK, Burnett AK, Chopra R, Wiernik PH, Foroni L, Paietta E (2008) In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation\/maintenance chemotherapy in all patients: final results of the International ALL Trial (MRC UKALL XII\/ECOG E2993). Blood 111(4):1827\u201333. https:\/\/doi.org\/10.1182\/blood-2007-10-116582","journal-title":"Blood"},{"issue":"9","key":"7030_CR16","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1200\/JCO.21.01405","volume":"40","author":"RM Myers","year":"2021","unstructured":"Myers RM, Taraseviciute A, Steinberg SM et al (2021) Blinatumomab Nonresponse and High-Disease Burden Are Associated With Inferior Outcomes After CD19-CAR for B-ALL. J Clin Oncol 40(9):932. https:\/\/doi.org\/10.1200\/JCO.21.01405","journal-title":"J Clin Oncol"},{"issue":"9","key":"7030_CR17","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1200\/JCO.20.03585","volume":"40","author":"LM Schultz","year":"2022","unstructured":"Schultz LM, Baggott C, Prabhu S et al (2022) Disease Burden Affects Outcomes in Pediatric and Young Adult B-Cell Lymphoblastic Leukemia After Commercial Tisagenlecleucel: A Pediatric Real-World Chimeric Antigen Receptor Consortium Report. J Clin Oncol 40(9):945\u2013955. https:\/\/doi.org\/10.1200\/JCO.20.03585","journal-title":"J Clin Oncol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-026-07030-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-026-07030-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-026-07030-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T09:21:48Z","timestamp":1778750508000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-026-07030-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,29]]},"references-count":17,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["7030"],"URL":"https:\/\/doi.org\/10.1007\/s00277-026-07030-z","relation":{},"ISSN":["1432-0584"],"issn-type":[{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,29]]},"assertion":[{"value":"21 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective study was approved by the Ethics Committee of The First Affiliated Hospital of Soochow University (ethical approval protocol number 2025285). All methods were performed in accordance with the relevant laws and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Given the retrospective nature of the present analysis, the requirement for additional informed consent for this study was waived by the institutional review board.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interests"}},{"value":"All authors disclosed no relevant relationship.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}],"article-number":"271"}}